Showing results (271-280 of 308) with videos related to
Sort By:
Pageof 31
JAMA|January 19, 2024
Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent PatientsSteven T Bird, Elizabeth R Smith, Kate Gelperin, et al.Journal of the National Cancer Institute|October 6, 2023
Trends in new and persistent opioid use in older adults with and without cancerLaura Van Metre Baum, Madhav Kc, Pamela R Soulos, et al.JAMA Oncology|December 20, 2019
Idelalisib for Treatment of Relapsed Follicular Lymphoma and Chronic Lymphocytic Leukemia: A Comparison of Treatment Outcomes in Clinical Trial Participants vs Medicare BeneficiariesSteven T Bird, Fang Tian, Natasha Flowers, et al.Tissue Engineering. Part C, Methods|March 8, 2011
A whole-organ regenerative medicine approach for liver replacementAlejandro Soto-Gutierrez, Li Zhang, Chris Medberry, et al.JAMA Internal Medicine|October 25, 2016
Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service MedicareCunlin Wang, Robert Kane, Mark Levenson, et al.International Journal of Molecular Sciences|July 2, 2021
Yes-Associated Protein (Yap) Is Up-Regulated in Heart Failure and Promotes Cardiac Fibroblast ProliferationMaryam Sharifi-Sanjani, Mariah Berman, Dmitry Goncharov, et al.Pharmacoepidemiology and Drug Safety|November 10, 2025
Validation of the US Food and Drug Administration's COVID-19 Disease Severity Categorization for Use in Real-World DataSilvia Perez-Vilar, Wei Hua, Andrew Kwist, et al.Cancer|September 22, 2025
Opioid prescribing trends and pain scores among adult patients with cancer in a large health systemLaura Van Metre Baum, Pamela R Soulos, Madhav Kc, et al.Journal of General Internal Medicine|October 2, 2021
Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for HypertensionDavid J Graham, Hector S Izurieta, Stella G Muthuri, et al.JCI Insight|January 17, 2020
Nrf2 activation protects against lithium-induced nephrogenic diabetes insipidusSoma Jobbagy, Dario A Vitturi, Sonia R Salvatore, et al.Pageof 31